Immunosuppressive premedication

Antibodies: Anti-CD20
Description

Antibodies: Anti-CD20

Alias
UMLS CUI-1
C3891557
Obinutuzumab in the last 6 months
Description

Recent: Obinutuzumab

Data type

integer

Alias
UMLS CUI [1,1]
C2742503
UMLS CUI [1,2]
C0332185
Ocrelizumab in the last 6 months
Description

Recent: Ocrelizumab

Data type

integer

Alias
UMLS CUI [1,1]
C1882138
UMLS CUI [1,2]
C0332185
Ofatumumab in the last 3 months
Description

Recent: Ofatumumab

Data type

integer

Alias
UMLS CUI [1,1]
C1832027
UMLS CUI [1,2]
C0332185
Rituximab in the last 6 months
Description

Recent: Rituximab

Data type

integer

Alias
UMLS CUI [1,1]
C0393022
UMLS CUI [1,2]
C0332185
Antibodies: CD-22
Description

Antibodies: CD-22

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C0054947
Inotuzumab-Ozogamicin
Description

Inotuzumab-Ozogamicin

Data type

integer

Alias
UMLS CUI [1]
C1567130
Antibodies: CD-38
Description

Antibodies: CD-38

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C0075742
Daratumumab
Description

Daratumumab

Data type

integer

Alias
UMLS CUI [1]
C2346801
Antibodies: CD-52
Description

Antibodies: CD-52

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C1610534
Alemtuzumab in the last 12 months
Description

Recent: Alemtuzumab

Data type

integer

Alias
UMLS CUI [1,1]
C0383429
UMLS CUI [1,2]
C0332185
Antibodies: Anti-CD79b
Description

Antibodies: Anti-CD79b

Alias
UMLS CUI-1
C0104979
UMLS CUI-2
C0003241
Polatuzumab-Vedotin
Description

Polatuzumab-Vedotin

Data type

integer

Alias
UMLS CUI [1]
C4078806
Antibodies: B Lymphocyte stimulator-specific inhibitor (BLyS)
Description

Antibodies: B Lymphocyte stimulator-specific inhibitor (BLyS)

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C3160093
Belimumab in the last 6 months
Description

Recent: Belimumab

Data type

integer

Alias
UMLS CUI [1,1]
C1723401
UMLS CUI [1,2]
C0332185
Antibodies: CD19-BiTE
Description

Antibodies: CD19-BiTE

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C4727095
Blinatumomab
Description

Blinatumomab

Data type

integer

Alias
UMLS CUI [1]
C3853839
Antibodies: Complement inhibitors
Description

Antibodies: Complement inhibitors

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C1564892
Crovalimab
Description

Crovalimab

Data type

integer

Alias
UMLS CUI [1,1]
C1564892
UMLS CUI [1,2]
C3846158
Eculizumab
Description

Eculizumab

Data type

integer

Alias
UMLS CUI [1]
C1541483
Pegcetacoplan (APL-2)
Description

Pegcetacoplan (APL-2)

Data type

integer

Alias
UMLS CUI [1]
C4053680
Ravulizumab
Description

Ravulizumab

Data type

integer

Alias
UMLS CUI [1]
C4550350
Antibodies: Integrin antagonists
Description

Antibodies: Integrin antagonists

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C2917367
Natalizumab
Description

Natalizumab

Data type

integer

Alias
UMLS CUI [1]
C1172734
Vedolizumab
Description

Vedolizumab

Data type

integer

Alias
UMLS CUI [1]
C2742797
Antibodies: Interleukin inhibitors
Description

Antibodies: Interleukin inhibitors

Alias
UMLS CUI-1
C3653320
UMLS CUI-2
C0003241
Basiliximab
Description

Basiliximab

Data type

integer

Alias
UMLS CUI [1]
C0676831
Canakinumab
Description

Canakinumab

Data type

integer

Alias
UMLS CUI [1]
C2718773
Ixekizumab
Description

Ixekizumab

Data type

integer

Alias
UMLS CUI [1]
C3489764
Sarilumab
Description

Sarilumab

Data type

integer

Alias
UMLS CUI [1]
C3885145
Secukinumab
Description

Secukinumab

Data type

integer

Alias
UMLS CUI [1]
C3179547
Tocilizumab
Description

Tocilizumab

Data type

integer

Alias
UMLS CUI [1]
C1609165
Ustekinumab
Description

Ustekinumab

Data type

integer

Alias
UMLS CUI [1]
C1608841
Antibodies: TNF-alpha inhibitors
Description

Antibodies: TNF-alpha inhibitors

Alias
UMLS CUI-1
C3653350
UMLS CUI-2
C0003241
Adalimumab
Description

Adalimumab

Data type

integer

Alias
UMLS CUI [1]
C1122087
Certolizumab
Description

Certolizumab

Data type

integer

Alias
UMLS CUI [1]
C1872109
Etanercept
Description

Etanercept

Data type

integer

Alias
UMLS CUI [1]
C0717758
Golimumab
Description

Golimumab

Data type

integer

Alias
UMLS CUI [1]
C2353893
Infliximab
Description

Infliximab

Data type

integer

Alias
UMLS CUI [1]
C0666743
Other Antibodies
Description

Other Antibodies

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C0205394
Other Antibodies
Description

Other Antibodies

Data type

integer

Alias
UMLS CUI [1,1]
C0003241
UMLS CUI [1,2]
C0205394
Indicate other Antibodies
Description

Indicate other Antibodies

Data type

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C1521902
UMLS CUI [1,3]
C0003241
Inhibitors: Co-stimulation inhibitors
Description

Inhibitors: Co-stimulation inhibitors

Alias
UMLS CUI-1
C0003241
UMLS CUI-2
C1622572
UMLS CUI-3
C1999216
Abatacept
Description

Abatacept

Data type

integer

Alias
UMLS CUI [1]
C1619966
Belatacept
Description

Belatacept

Data type

integer

Alias
UMLS CUI [1]
C1619962
Inhibitors: Calcineurin inhibitors
Description

Inhibitors: Calcineurin inhibitors

Alias
UMLS CUI-1
C1562036
Ciclosporin
Description

Ciclosporin

Data type

integer

Alias
UMLS CUI [1]
C0010592
Pimecrolimus
Description

Pimecrolimus

Data type

integer

Alias
UMLS CUI [1]
C1099414
Tacrolimus
Description

Tacrolimus

Data type

integer

Alias
UMLS CUI [1]
C0085149
Inhibitors: Interleukin inhibitor
Description

Inhibitors: Interleukin inhibitor

Alias
UMLS CUI-1
C3653320
Anakinra
Description

Anakinra

Data type

integer

Alias
UMLS CUI [1]
C0245109
Inhibitors: JAK inhibitors
Description

Inhibitors: JAK inhibitors

Alias
UMLS CUI-1
C3854325
Baricitinib
Description

Baricitinib

Data type

integer

Alias
UMLS CUI [1]
C4044947
Fedratinib
Description

Fedratinib

Data type

integer

Alias
UMLS CUI [1]
C3886623
Ruxolitinib
Description

Ruxolitinib

Data type

integer

Alias
UMLS CUI [1]
C2931926
Tofacitinib
Description

Tofacitinib

Data type

integer

Alias
UMLS CUI [1]
C2930696
Upadacitinib
Description

Upadacitinib

Data type

integer

Alias
UMLS CUI [1]
C4726929
Inhibitors: mTOR inhibitors
Description

Inhibitors: mTOR inhibitors

Alias
UMLS CUI-1
C2746052
Everolimus
Description

Everolimus

Data type

integer

Alias
UMLS CUI [1]
C0541315
Sirolimus
Description

Sirolimus

Data type

integer

Alias
UMLS CUI [1]
C0072980
Inhibitor: PDE-4-inhibitor
Description

Inhibitor: PDE-4-inhibitor

Alias
UMLS CUI-1
C2936609
Apremilast
Description

Apremilast

Data type

integer

Alias
UMLS CUI [1]
C1678805
Other Inhibitors
Description

Other Inhibitors

Alias
UMLS CUI-1
C0205394
UMLS CUI-2
C0243077
Other inhibitors
Description

Other inhibitors

Data type

integer

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0243077
Indicate other inhibitors
Description

Indicate other inhibitors

Data type

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C1521902
UMLS CUI [1,3]
C0243077
Checkpoint inhibitors: last 3 months
Description

Checkpoint inhibitors: last 3 months

Alias
UMLS CUI-1
C0332185
UMLS CUI-2
C4733472
Nivolumab in the last 3 months
Description

In case of combination therapy please indicate all of the respective drugs.

Data type

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C3657270
Pembrolizumab in the last 3 months
Description

In case of combination therapy please indicate all of the respective drugs.

Data type

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C3658706
Ipilimumab in the last 3 months
Description

In case of combination therapy please indicate all of the respective drugs.

Data type

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C1367202
Other checkpoint inhibitor in the last 3 months
Description

In case of combination therapy please indicate all of the respective drugs.

Data type

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C4733472
Indicate other checkpoint inhibitor in the last 3 months
Description

Indicate recent other checkpoint inhibitor

Data type

text

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C4733472
UMLS CUI [1,4]
C1521902
No checkpoint inhibitor therapy in the last 3 months
Description

No recent checkpoint inhibitor therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1298908
UMLS CUI [1,2]
C0332185
UMLS CUI [1,3]
C4733472
Unknown
Description

Unknown Checkpoint inhibitor therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0439673
UMLS CUI [1,2]
C0332185
UMLS CUI [1,3]
C4733472
Chemotherapeutics: Antimetabolites
Description

Chemotherapeutics: Antimetabolites

Alias
UMLS CUI-1
C0003376
UMLS CUI-2
C0729502
6-Mercaptopurine
Description

6-Mercaptopurine

Data type

integer

Alias
UMLS CUI [1]
C0000618
Azathioprine
Description

Azathioprine

Data type

integer

Alias
UMLS CUI [1]
C0004482
Leflunomide
Description

Leflunomide

Data type

integer

Alias
UMLS CUI [1]
C0063041
Methotrexate
Description

Methotrexate

Data type

integer

Alias
UMLS CUI [1]
C0025677
Mycophenolate mofetil / Mycophenolic acid
Description

Mycophenolate mofetil / Mycophenolic acid

Data type

integer

Alias
UMLS CUI [1]
C0209368
UMLS CUI [2]
C0026933
Sulfasalazine
Description

Sulfasalazine

Data type

integer

Alias
UMLS CUI [1]
C0036078
Teriflunomide
Description

Teriflunomide

Data type

integer

Alias
UMLS CUI [1]
C1718383
Chemotherapeutics: Cytostatics
Description

Chemotherapeutics: Cytostatics

Alias
UMLS CUI-1
C0010858
UMLS CUI-2
C0729502
Cladribine (2-CDA) i.v./s.c. in the last 12 months
Description

Recent: Cladribine (2-CDA) i.v./s.c.

Data type

integer

Alias
UMLS CUI [1,1]
C0092801
UMLS CUI [1,2]
C0348016
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C0092801
UMLS CUI [2,2]
C0021499
UMLS CUI [2,3]
C0332185
Cladribine (2-CDA) p.o. in the last 12 months
Description

Recent: Cladribine (2-CDA) p.o.

Data type

integer

Alias
UMLS CUI [1,1]
C0092801
UMLS CUI [1,2]
C0001563
UMLS CUI [1,3]
C0332185
Cyclophosphamide i.v. in the last 3 months
Description

Recent: Cyclophosphamide i.v.

Data type

integer

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C0348016
UMLS CUI [1,3]
C0332185
Cyclophosphamide p.o. in the last 3 months
Description

Recent: Cyclophosphamide p.o.

Data type

integer

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C0001563
UMLS CUI [1,3]
C0332185
Mitoxantrone in the last 3 months
Description

Recent: Mitoxantrone

Data type

integer

Alias
UMLS CUI [1,1]
C0026259
UMLS CUI [1,2]
C0332185
Other Chemotherapeutics
Description

Other Chemotherapeutics

Alias
UMLS CUI-1
C0205394
UMLS CUI-2
C0729502
Other Chemotherapeutics
Description

Other Chemotherapeutics

Data type

integer

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0729502
Indicate other Chemotherapeutics
Description

Indicate other Chemotherapeutics

Data type

text

Alias
UMLS CUI [1,1]
C0729502
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C1521902
Other immunosuppressive regimens: Corticosteroids
Description

Other immunosuppressive regimens: Corticosteroids

Alias
UMLS CUI-1
C0021081
UMLS CUI-2
C0205394
UMLS CUI-3
C0001617
< 10 mg / d prednisolone equivalent
Description

low dose prednisolone equivalent

Data type

integer

Alias
UMLS CUI [1,1]
C0445550
UMLS CUI [1,2]
C0038317
10 - 100 mg / d prednisolone equivalent
Description

medium dose prednisolone equivalent

Data type

integer

Alias
UMLS CUI [1,1]
C0439536
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0038317
> 100 mg / d prednisolone equivalent
Description

high dose prednisolone equivalent

Data type

integer

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0444956
Other immunosuppressive regimens: Fumarate
Description

Other immunosuppressive regimens: Fumarate

Alias
UMLS CUI-1
C0021081
UMLS CUI-2
C0205394
UMLS CUI-3
C0220833
Dimethyl fumarate
Description

Dimethyl fumarate

Data type

integer

Alias
UMLS CUI [1]
C0058218
Dimethyl fumarate / ethyl hydrogen fumarate
Description

Dimethyl fumarate/ethyl hydrogen fumarate (Fumaderm)

Data type

integer

Alias
UMLS CUI [1,1]
C0058218
UMLS CUI [1,2]
C0059764
UMLS CUI [2]
C0633802
Other immunosuppressive regimens: Immunoglobulines
Description

Other immunosuppressive regimens: Immunoglobulines

Alias
UMLS CUI-1
C1963758
UMLS CUI-2
C0205394
UMLS CUI-3
C0021081
Immunoglobulins i.v.
Description

Immunoglobulins i.v.

Data type

integer

Alias
UMLS CUI [1,1]
C0021027
UMLS CUI [1,2]
C0348016
Immunoglobulins s.c.
Description

Immunoglobulins s.c.

Data type

integer

Alias
UMLS CUI [1,1]
C0021027
UMLS CUI [1,2]
C0021499
Other immunosuppressive regimens: Interferon
Description

Other immunosuppressive regimens: Interferon

Alias
UMLS CUI-1
C0021081
UMLS CUI-2
C0205394
UMLS CUI-3
C3652465
Interferon-alpha
Description

Interferon-alpha

Data type

integer

Alias
UMLS CUI [1]
C0002199
Interferon-beta
Description

Interferon-beta

Data type

integer

Alias
UMLS CUI [1]
C0015980
Other immunosuppressive regimens: Other Multiple Sclerosis drugs
Description

Other immunosuppressive regimens: Other Multiple Sclerosis drugs

Alias
UMLS CUI-1
C0021081
UMLS CUI-2
C0205394
UMLS CUI-3
C0013227
UMLS CUI-4
C0026769
Glatirameracetat
Description

Glatirameracetat

Data type

integer

Alias
UMLS CUI [1]
C0289884
Fingolimod
Description

Fingolimod

Data type

integer

Alias
UMLS CUI [1]
C1699926
Siponimod
Description

Siponimod

Data type

integer

Alias
UMLS CUI [1]
C3657824
Other immunosuppressive regimens
Description

Other immunosuppressive regimens

Alias
UMLS CUI-1
C0205394
UMLS CUI-2
C0021081
Other immunosuppressive drugs
Description

Other immunosuppressive drugs

Data type

integer

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C0205394
Indicate other immunosuppressive drugs
Description

Indicate other immunosuppressive drugs

Data type

text

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C1521902
Immunosuppressive drugs: Underlying disease
Description

Immunosuppressive drugs: Underlying disease

Alias
UMLS CUI-1
C0021081
UMLS CUI-2
C3146298
Multiple Sclerosis
Description

Please indicate the underlying disease which has lead to the use of the indicated treatments. E.g. a patient might has suffered from breast cancer but the immunosuppressive treatment is due to a rheumatic disease with a lower dosis than it would be used in case of anticancer treatment. In this case only rheumatic disease should be indicated.

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0026769
Other neurological autoimmune diseases
Description

Please indicate the underlying disease which has lead to the use of the indicated treatments. E.g. a patient might has suffered from breast cancer but the immunosuppressive treatment is due to a rheumatic disease with a lower dosis than it would be used in case of anticancer treatment. In this case only rheumatic disease should be indicated.

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0205494
UMLS CUI [1,4]
C0004364
UMLS CUI [1,5]
C0205394
Oncology
Description

Please indicate the underlying disease which has lead to the use of the indicated treatments. E.g. a patient might has suffered from breast cancer but the immunosuppressive treatment is due to a rheumatic disease with a lower dosis than it would be used in case of anticancer treatment. In this case only rheumatic disease should be indicated.

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0205478
Organ transplantation
Description

Please indicate the underlying disease which has lead to the use of the indicated treatments. E.g. a patient might has suffered from breast cancer but the immunosuppressive treatment is due to a rheumatic disease with a lower dosis than it would be used in case of anticancer treatment. In this case only rheumatic disease should be indicated.

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0029216
Rheumatic diseases
Description

Please indicate the underlying disease which has lead to the use of the indicated treatments. E.g. a patient might has suffered from breast cancer but the immunosuppressive treatment is due to a rheumatic disease with a lower dosis than it would be used in case of anticancer treatment. In this case only rheumatic disease should be indicated.

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C3495832
Other Underlying disease
Description

Please indicate the underlying disease which has lead to the use of the indicated treatments. E.g. a patient might has suffered from breast cancer but the immunosuppressive treatment is due to a rheumatic disease with a lower dosis than it would be used in case of anticancer treatment. In this case only rheumatic disease should be indicated.

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0277554
UMLS CUI [1,4]
C0205394
Indicate other Underlying disease
Description

Please indicate the underlying disease which has lead to the use of the indicated treatments. E.g. a patient might has suffered from breast cancer but the immunosuppressive treatment is due to a rheumatic disease with a lower dosis than it would be used in case of anticancer treatment. In this case only rheumatic disease should be indicated.

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0277554
UMLS CUI [1,4]
C0205394
UMLS CUI [1,5]
C1521902
Unknown
Description

Indication for immunosuppressive drugs: Unknown underlying disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0439673
UMLS CUI [1,4]
C0277554
Is data entry for this section finished?
Description

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Description

Is data entry for this section finished?

Data type

boolean

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197

Similar models

Immunosuppressive premedication

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Antibodies: Anti-CD20
C3891557 (UMLS CUI-1)
Item
Obinutuzumab in the last 6 months
integer
C2742503 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Code List
Obinutuzumab in the last 6 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ocrelizumab in the last 6 months
integer
C1882138 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Code List
Ocrelizumab in the last 6 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ofatumumab in the last 3 months
integer
C1832027 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Code List
Ofatumumab in the last 3 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Rituximab in the last 6 months
integer
C0393022 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Code List
Rituximab in the last 6 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: CD-22
C0003241 (UMLS CUI-1)
C0054947 (UMLS CUI-2)
Item
Inotuzumab-Ozogamicin
integer
C1567130 (UMLS CUI [1])
Code List
Inotuzumab-Ozogamicin
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: CD-38
C0003241 (UMLS CUI-1)
C0075742 (UMLS CUI-2)
Item
Daratumumab
integer
C2346801 (UMLS CUI [1])
Code List
Daratumumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: CD-52
C0003241 (UMLS CUI-1)
C1610534 (UMLS CUI-2)
Item
Alemtuzumab in the last 12 months
integer
C0383429 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Code List
Alemtuzumab in the last 12 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Anti-CD79b
C0104979 (UMLS CUI-1)
C0003241 (UMLS CUI-2)
Item
Polatuzumab-Vedotin
integer
C4078806 (UMLS CUI [1])
Code List
Polatuzumab-Vedotin
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: B Lymphocyte stimulator-specific inhibitor (BLyS)
C0003241 (UMLS CUI-1)
C3160093 (UMLS CUI-2)
Item
Belimumab in the last 6 months
integer
C1723401 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Code List
Belimumab in the last 6 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: CD19-BiTE
C0003241 (UMLS CUI-1)
C4727095 (UMLS CUI-2)
Item
Blinatumomab
integer
C3853839 (UMLS CUI [1])
Code List
Blinatumomab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Complement inhibitors
C0003241 (UMLS CUI-1)
C1564892 (UMLS CUI-2)
Item
Crovalimab
integer
C1564892 (UMLS CUI [1,1])
C3846158 (UMLS CUI [1,2])
Code List
Crovalimab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Eculizumab
integer
C1541483 (UMLS CUI [1])
Code List
Eculizumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Pegcetacoplan (APL-2)
integer
C4053680 (UMLS CUI [1])
Code List
Pegcetacoplan (APL-2)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ravulizumab
integer
C4550350 (UMLS CUI [1])
Code List
Ravulizumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Integrin antagonists
C0003241 (UMLS CUI-1)
C2917367 (UMLS CUI-2)
Item
Natalizumab
integer
C1172734 (UMLS CUI [1])
Code List
Natalizumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Vedolizumab
integer
C2742797 (UMLS CUI [1])
Code List
Vedolizumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Interleukin inhibitors
C3653320 (UMLS CUI-1)
C0003241 (UMLS CUI-2)
Item
Basiliximab
integer
C0676831 (UMLS CUI [1])
Code List
Basiliximab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Canakinumab
integer
C2718773 (UMLS CUI [1])
Code List
Canakinumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ixekizumab
integer
C3489764 (UMLS CUI [1])
Code List
Ixekizumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Sarilumab
integer
C3885145 (UMLS CUI [1])
Code List
Sarilumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Secukinumab
integer
C3179547 (UMLS CUI [1])
Code List
Secukinumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Tocilizumab
integer
C1609165 (UMLS CUI [1])
Code List
Tocilizumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ustekinumab
integer
C1608841 (UMLS CUI [1])
Code List
Ustekinumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: TNF-alpha inhibitors
C3653350 (UMLS CUI-1)
C0003241 (UMLS CUI-2)
Item
Adalimumab
integer
C1122087 (UMLS CUI [1])
Code List
Adalimumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Certolizumab
integer
C1872109 (UMLS CUI [1])
Code List
Certolizumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Etanercept
integer
C0717758 (UMLS CUI [1])
Code List
Etanercept
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Golimumab
integer
C2353893 (UMLS CUI [1])
Code List
Golimumab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Infliximab
integer
C0666743 (UMLS CUI [1])
Code List
Infliximab
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other Antibodies
C0003241 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
Item
Other Antibodies
integer
C0003241 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Code List
Other Antibodies
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other Antibodies
Item
Indicate other Antibodies
text
C0205394 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,3])
Item Group
Inhibitors: Co-stimulation inhibitors
C0003241 (UMLS CUI-1)
C1622572 (UMLS CUI-2)
C1999216 (UMLS CUI-3)
Item
Abatacept
integer
C1619966 (UMLS CUI [1])
Code List
Abatacept
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Belatacept
integer
C1619962 (UMLS CUI [1])
Code List
Belatacept
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Inhibitors: Calcineurin inhibitors
C1562036 (UMLS CUI-1)
Item
Ciclosporin
integer
C0010592 (UMLS CUI [1])
Code List
Ciclosporin
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Pimecrolimus
integer
C1099414 (UMLS CUI [1])
Code List
Pimecrolimus
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Tacrolimus
integer
C0085149 (UMLS CUI [1])
Code List
Tacrolimus
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Inhibitors: Interleukin inhibitor
C3653320 (UMLS CUI-1)
Item
Anakinra
integer
C0245109 (UMLS CUI [1])
Code List
Anakinra
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Inhibitors: JAK inhibitors
C3854325 (UMLS CUI-1)
Item
Baricitinib
integer
C4044947 (UMLS CUI [1])
Code List
Baricitinib
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Fedratinib
integer
C3886623 (UMLS CUI [1])
Code List
Fedratinib
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ruxolitinib
integer
C2931926 (UMLS CUI [1])
Code List
Ruxolitinib
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Tofacitinib
integer
C2930696 (UMLS CUI [1])
Code List
Tofacitinib
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Upadacitinib
integer
C4726929 (UMLS CUI [1])
Code List
Upadacitinib
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Inhibitors: mTOR inhibitors
C2746052 (UMLS CUI-1)
Item
Everolimus
integer
C0541315 (UMLS CUI [1])
Code List
Everolimus
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Sirolimus
integer
C0072980 (UMLS CUI [1])
Code List
Sirolimus
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Inhibitor: PDE-4-inhibitor
C2936609 (UMLS CUI-1)
Item
Apremilast
integer
C1678805 (UMLS CUI [1])
Code List
Apremilast
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other Inhibitors
C0205394 (UMLS CUI-1)
C0243077 (UMLS CUI-2)
Item
Other inhibitors
integer
C0205394 (UMLS CUI [1,1])
C0243077 (UMLS CUI [1,2])
Code List
Other inhibitors
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other inhibitors
Item
Indicate other inhibitors
text
C0205394 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
C0243077 (UMLS CUI [1,3])
Item Group
Checkpoint inhibitors: last 3 months
C0332185 (UMLS CUI-1)
C4733472 (UMLS CUI-2)
Recent: Nivolumab
Item
Nivolumab in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C3657270 (UMLS CUI [1,2])
Recent: Pembrolizumab
Item
Pembrolizumab in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C3658706 (UMLS CUI [1,2])
Recent: Ipilimumab
Item
Ipilimumab in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C1367202 (UMLS CUI [1,2])
Recent: Other checkpoint inhibitor
Item
Other checkpoint inhibitor in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
Indicate recent other checkpoint inhibitor
Item
Indicate other checkpoint inhibitor in the last 3 months
text
C0332185 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
No recent checkpoint inhibitor therapy
Item
No checkpoint inhibitor therapy in the last 3 months
boolean
C1298908 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
Unknown Checkpoint inhibitor therapy
Item
Unknown
boolean
C0439673 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
Item Group
Chemotherapeutics: Antimetabolites
C0003376 (UMLS CUI-1)
C0729502 (UMLS CUI-2)
Item
6-Mercaptopurine
integer
C0000618 (UMLS CUI [1])
Code List
6-Mercaptopurine
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Azathioprine
integer
C0004482 (UMLS CUI [1])
Code List
Azathioprine
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Leflunomide
integer
C0063041 (UMLS CUI [1])
Code List
Leflunomide
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Methotrexate
integer
C0025677 (UMLS CUI [1])
Code List
Methotrexate
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Mycophenolate mofetil / Mycophenolic acid
integer
C0209368 (UMLS CUI [1])
C0026933 (UMLS CUI [2])
Code List
Mycophenolate mofetil / Mycophenolic acid
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Sulfasalazine
integer
C0036078 (UMLS CUI [1])
Code List
Sulfasalazine
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Teriflunomide
integer
C1718383 (UMLS CUI [1])
Code List
Teriflunomide
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Chemotherapeutics: Cytostatics
C0010858 (UMLS CUI-1)
C0729502 (UMLS CUI-2)
Item
Cladribine (2-CDA) i.v./s.c. in the last 12 months
integer
C0092801 (UMLS CUI [1,1])
C0348016 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0092801 (UMLS CUI [2,1])
C0021499 (UMLS CUI [2,2])
C0332185 (UMLS CUI [2,3])
Code List
Cladribine (2-CDA) i.v./s.c. in the last 12 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cladribine (2-CDA) p.o. in the last 12 months
integer
C0092801 (UMLS CUI [1,1])
C0001563 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Code List
Cladribine (2-CDA) p.o. in the last 12 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cyclophosphamide i.v. in the last 3 months
integer
C0010583 (UMLS CUI [1,1])
C0348016 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Code List
Cyclophosphamide i.v. in the last 3 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cyclophosphamide p.o. in the last 3 months
integer
C0010583 (UMLS CUI [1,1])
C0001563 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Code List
Cyclophosphamide p.o. in the last 3 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Mitoxantrone in the last 3 months
integer
C0026259 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Code List
Mitoxantrone in the last 3 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other Chemotherapeutics
C0205394 (UMLS CUI-1)
C0729502 (UMLS CUI-2)
Item
Other Chemotherapeutics
integer
C0205394 (UMLS CUI [1,1])
C0729502 (UMLS CUI [1,2])
Code List
Other Chemotherapeutics
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other Chemotherapeutics
Item
Indicate other Chemotherapeutics
text
C0729502 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item Group
Other immunosuppressive regimens: Corticosteroids
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0001617 (UMLS CUI-3)
Item
< 10 mg / d prednisolone equivalent
integer
C0445550 (UMLS CUI [1,1])
C0038317 (UMLS CUI [1,2])
Code List
< 10 mg / d prednisolone equivalent
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
10 - 100 mg / d prednisolone equivalent
integer
C0439536 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0038317 (UMLS CUI [1,3])
Code List
10 - 100 mg / d prednisolone equivalent
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
> 100 mg / d prednisolone equivalent
integer
C0038317 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
Code List
> 100 mg / d prednisolone equivalent
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Fumarate
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0220833 (UMLS CUI-3)
Item
Dimethyl fumarate
integer
C0058218 (UMLS CUI [1])
Code List
Dimethyl fumarate
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Dimethyl fumarate / ethyl hydrogen fumarate
integer
C0058218 (UMLS CUI [1,1])
C0059764 (UMLS CUI [1,2])
C0633802 (UMLS CUI [2])
Code List
Dimethyl fumarate / ethyl hydrogen fumarate
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Immunoglobulines
C1963758 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0021081 (UMLS CUI-3)
Item
Immunoglobulins i.v.
integer
C0021027 (UMLS CUI [1,1])
C0348016 (UMLS CUI [1,2])
Code List
Immunoglobulins i.v.
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Immunoglobulins s.c.
integer
C0021027 (UMLS CUI [1,1])
C0021499 (UMLS CUI [1,2])
Code List
Immunoglobulins s.c.
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Interferon
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C3652465 (UMLS CUI-3)
Item
Interferon-alpha
integer
C0002199 (UMLS CUI [1])
Code List
Interferon-alpha
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Interferon-beta
integer
C0015980 (UMLS CUI [1])
Code List
Interferon-beta
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Other Multiple Sclerosis drugs
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
C0026769 (UMLS CUI-4)
Item
Glatirameracetat
integer
C0289884 (UMLS CUI [1])
Code List
Glatirameracetat
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Fingolimod
integer
C1699926 (UMLS CUI [1])
Code List
Fingolimod
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Siponimod
integer
C3657824 (UMLS CUI [1])
Code List
Siponimod
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens
C0205394 (UMLS CUI-1)
C0021081 (UMLS CUI-2)
Item
Other immunosuppressive drugs
integer
C0021081 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Code List
Other immunosuppressive drugs
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other immunosuppressive drugs
Item
Indicate other immunosuppressive drugs
text
C0021081 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item Group
Immunosuppressive drugs: Underlying disease
C0021081 (UMLS CUI-1)
C3146298 (UMLS CUI-2)
Indication for immunosuppressive drugs: Multiple Sclerosis
Item
Multiple Sclerosis
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Other neurological autoimmune diseases
Item
Other neurological autoimmune diseases
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0205494 (UMLS CUI [1,3])
C0004364 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,5])
Indication for immunosuppressive drugs: Oncology
Item
Oncology
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0205478 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Organ transplantation
Item
Organ transplantation
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0029216 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Rheumatic diseases
Item
Rheumatic diseases
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C3495832 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Other Underlying disease
Item
Other Underlying disease
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
Indication for immunosuppressive drugs: Indicate other Underlying disease
Item
Indicate other Underlying disease
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C1521902 (UMLS CUI [1,5])
Indication for immunosuppressive drugs: Unknown underlying disease
Item
Unknown
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0277554 (UMLS CUI [1,4])
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Is data entry for this section finished?
Item
Is data entry for this section finished?
boolean
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])